JANA Partners Urges All Charles River Shareholders to Vote Against Proposed WuXi Acquisition

JANA Partners today urged all stockholders of Charles River Laboratories International, Inc. CRL to vote against the issuance of shares needed to complete the proposed acquisition of WuXi PharmaTech (Cayman) Inc. WX, and against giving Charles River the right to adjourn next week's special meeting. JANA Partners noted that both ISS/RiskMetrics Group and Glass Lewis & Co. have recommended that Charles River stockholders vote against both proposals.